
|Videos|August 21, 2020
2020 vision: The future of ophthalmology (Part II)
Author(s)Alex Delaney-Gesing , David Hutton
In this second installment, ophthalmologists share how their expectations for "the year of the eye" have compared and contrasted to reality amid the global pandemic.
Advertisement
Alice Epitropoulos, MD, FACS (Cataract and Refractive Center of Ohio), and Dee Stephenson, MD, FACS (president, American Board of Eye Surgery), speak with Ophthalmology Times'® David Hutton on how the use of telemedicine for patient care during the coronavirus pandemic may be the new norm, what's in the lens pipeline, as well as how the expectation versus reality for 2020 in the ophthalmic space have compared.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities
2
Memento Medicines launches with $93 million Series A to advance Tie2-activating bispecific for retinal disease
3
Obstructive sleep apnea and glaucoma: What a 12.5-million-patient data set reveals
4
Meta's AI glasses for veterans: Canto-Sims, OD on closing the access gap
5


























